Indicated for stage 1A and 1B mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy
Utilized as a thin film of gel topically to affected areas of the skin once daily.
Treatment is stopped for any grade of skin ulceration, blistering, or severe dermatitis, and is resumed at reduced application frequency.
Washing of hands thoroughly with soap and water after handling or applying this drug, and caregivers must wear disposable nitrile gloves when applying gel.